Halozyme Therapeutics shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $340k | 4.6k | 73.34 |
| 2024-09-30 | $3.8M | 66k | 57.24 |
| 2024-06-30 | $3.7M | 71k | 52.36 |
| 2024-03-31 | $3.0M | 75k | 40.68 |
| 2023-12-31 | $2.6M | 71k | 36.96 |
| 2023-09-30 | $2.7M | 70k | 38.20 |
| 2023-06-30 | $2.0M | 57k | 36.07 |
| 2023-03-31 | $1.4M | 37k | 38.18 |
| 2022-12-31 | $1.9M | 33k | 56.90 |
| 2022-09-30 | $395k | 10k | 39.44 |
| 2022-06-30 | $0 | 11k | 0.00 |
| 2022-03-31 | $331k | 8.3k | 39.85 |
| 2021-12-31 | $343k | 8.5k | 40.12 |
| 2021-09-30 | $338k | 8.3k | 40.66 |
| 2021-06-30 | $26k | 573 | 45.38 |
| 2021-03-31 | $22k | 533 | 41.28 |
| 2020-12-31 | $21k | 500 | 42.00 |
| 2020-09-30 | $13k | 500 | 26.00 |
| 2020-06-30 | $163k | 6.1k | 26.84 |
| 2020-03-31 | $131k | 7.3k | 17.93 |
| 2019-12-31 | $9.0k | 500 | 18.00 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management